Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Georg Schett, Silvia Spoerl et al.|The Lancet Rheumatology|2025Cited by 71
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Georg Schett, Melanie Hagen et al.|Nature Medicine|2026Cited by 43